文献速递主动脉疾病

女性腹主动脉瘤修复术后早期死亡率的系统综述与荟萃分析:急诊与择期情境下血管内修复与开放手术的比较

A systematic review and meta-analysis on early mortality after abdominal aortic aneurysm repair in females in urgent and elective settings.
PubMed 文献 · J Vasc Surg · 2021-11-03

该系统综述与荟萃分析纳入8项研究、共56982例女性腹主动脉瘤修复患者(EVAR 22995例 vs OSR 33987例),比较急诊与择期情境下EVAR与OSR的30天死亡率。结果显示女性EVAR的30天死亡率低于OSR(OR 0.25,95%CI 0.23-0.27,P<.001,I²=86%),择期与急诊情境下结论一致;但急诊情境下OSR更常被实施(OR 0.21,95%CI 0.19-0.23,P<.001,I²=84%)。

要点

  • 女性AAA修复中EVAR的30天死亡率低于OSR(OR 0.25,95%CI 0.23-0.27,P<.001,I²=86%)。
  • 择期情境下女性EVAR的30天死亡率低于OSR(OR 0.37,95%CI 0.33-0.41,P<.001,I²=48%)。
  • 急诊情境下EVAR的30天死亡率低于OSR(OR 0.48,95%CI 0.40-0.57,P<.001,I²=0%),但OSR更常被实施(OR 0.21,95%CI 0.19-0.23,P<.001,I²=84%)。

核心结论

  • 在女性中,EVAR在择期和急诊AAA修复中均与较低的30天死亡率相关,尽管在急诊AAA修复中EVAR似乎较少被提供。

研究设计与样本

  • 系统综述与荟萃分析,方案注册于PROSPERO数据库(CRD42021242686)。
  • 检索PubMed、EMBASE和CENTRAL数据库,从建库至2021年3月5日,遵循PRISMA指南。
  • 纳入报告女性人群急诊与择期情境下EVAR与OSR的AAA修复30天死亡率的英文研究,症状性和破裂病例归入急诊组。
  • 共纳入8项研究,总计56982例女性(EVAR 22995例 vs OSR 33987例)。
  • 使用ROBINS-I工具评估个体研究偏倚风险,采用GRADE方法评价证据质量。

主要发现

  • 女性EVAR与OSR相比,总30天死亡率显著降低(OR 0.25,95%CI 0.23-0.27,P<.001,I²=86%)。
  • 择期情境下女性EVAR的30天死亡率低于OSR(OR 0.37,95%CI 0.33-0.41,P<.001,I²=48%)。
  • 急诊情境下OSR更常被实施(OR 0.21,95%CI 0.19-0.23,P<.001,I²=84%)。
  • 急诊情境下EVAR与较低的30天死亡率相关(OR 0.48,95%CI 0.40-0.57,P<.001,I²=0%)。

临床怎么用

  • 作者结论认为,在女性中EVAR在择期和急诊AAA修复中均与较低的30天死亡率相关,尽管在急诊AAA修复中EVAR似乎较少被提供。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Females represent a group of patients with higher mortality after abdominal aortic aneurysm (AAA), endovascular (EVAR), or open surgical (OSR), repair. This systematic review aimed to evaluate the 30-day mortality after AAA repair in females, comparing both EVAR and OSR, in elective and urgent settings. METHODS: The protocol of the review was registered to the PROSPERO database (CRD42021242686). A search of the English literature was conducted, using PubMed, EMBASE, and CENTRAL databases, from inception to March 5, 2021, using the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines (PRISMA). Only studies reporting on 30-day mortality of AAA repair, in urgent and elective settings, comparing EVAR and OSR, in the female population were eligible. Patients were stratified according to the need for elective or urgent repair. Symptomatic and ruptured cases were included into the urgent group. Individual studies were assessed for risk of bias using the (Risk Of Bias In Non-randomised Studies - of Interventions) ROBINS-I tool. The Grading of Recommendations, Assessment, Development and Evaluations (GRADE) approach was used to evaluate the quality of evidence. The primary outcome was 30-day mortality after AAA repair in the female population, comparing EVAR and OSR. The outcomes were summarized as odds ratio, along with their 95% confidence intervals (CIs), through a paired meta-analysis. RESULTS: Eight studies reported data on 30-day mortality following AAA repair. A total of 56,982 females (22,995 EVAR vs 33,987 OSR) were included. A significantly reduced total 30-day mortality rate was recorded among females that underwent EVAR compared with OSR (odds ratio [OR], 0.25; 95% CI, 0.23-0.27; P < .001; Ι2 = 86%). In addition, a reduced 30-day mortality was found in females that underwent elective EVAR compared with OSR (OR, 0.37; 95% CI, 0.33-0.41; P < .001; Ι2 = 48%). Despite the fact that OSR was more frequently offered in the urgent setting (OR, 0.21; 95% CI, 0.19-0.23; P < .001; Ι2 = 84%), EVAR was associated with a reduced 30-day mortality (OR, 0.48; 95% CI, 0.40-0.57; P < .001; Ι2 = 0%). CONCLUSIONS: In females, EVAR is associated with lower 30-day mortality in both elective and urgent AAA repair, although it appears as less likely to be offered in the setting of urgent AAA repair.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Nana P, Dakis K, Brodis A, et al. A systematic review and meta-analysis on early mortality after abdominal aortic aneurysm repair in females in urgent and elective settings. J Vasc Surg. 2021. PMID: 34740807. doi:10.1016/j.jvs.2021.10.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。